The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor
Abstract
Because of its requirement for signaling by multiple cytokines, Janus kinase 3 (JAK3) is an excellent target for clinical immunosuppression. We report the development of a specific, orally active inhibitor of JAK3, CP-690,550, that significantly prolongedsurvival in a murine model of heart transplantation and in cynomolgus monkeys receiving kidney transplants. CP-690,550 treatment was not associatedwith hypertension, hyperlipidemia, or lymphoproliferative disease. On the basis of these preclinical results, we believe JAK3 blockade by CP-690,550 has potential for therapeutically desirable immunosuppression in human organ transplantation andin other clinical settings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the first JAK inhibitor to be developed targeted JAK3”
From Targeting Interleukin-6 Signaling in Clinic (2019) · cites this paper as Changelian et al., 2003
Citations
Cites
A Critical Role for IL-21 in Regulating Immunoglobulin Production
Ozaki, K., Spolski, R., Feng, C. G., Qi, C.-F., Cheng, J., Sher, A., Morse, H. C., Liu, C., Schwartzberg, P. L., & Leonard, W. J. (2002) · Science · doi:10.1126/science.1077002 · Cited by 978
Research works printed but not linked: 22
- 10.1034/j.1600-6143.2003.00115.x · DOI
- J. C. Hong, B. D. Kahan, Semin. Nephrol.20, 108 (2000).
- 10.1016/S0092-8674(02)00701-8 · DOI
- 10.1038/377065a0 · DOI
- 10.1126/science.270.5237.797 · DOI
- R. A. Copeland Enzymes a Practical Introduction to Structure Mechanism and Data Analysis (Wiley-VCH ed. 2 Baltimore).
- 10.1126/science.1071551 · DOI
- 10.1002/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U · DOI
- 10.4049/jimmunol.166.6.3724 · DOI
- 10.1182/blood.V99.11.4192 · DOI
- 10.1097/01.TP.0000065738.58742.A9 · DOI
- R. J. Corry, H. J. Winn, P. S. Russell, Transplant. Proc.5, 733 (1973).
- 10.4049/jimmunol.169.1.522 · DOI
- A. Saiuraet al., Transplantation72, 320 (2002).
- 10.1016/S0952-7915(02)00382-5 · DOI
- D. Borie et al., J. Surg. Res.107, 64 (2002).
- 10.1097/00007890-200109270-00025 · DOI
- 10.1046/j.1523-1755.1999.00299.x · DOI
- S. J. Sohn et al., J. Immunol.160, 2130 (1998). · DOI
- 10.4049/jimmunol.166.2.727 · DOI
- 10.1038/nri1088 · DOI
- 10.1172/JCI9083 · DOI · Paper page
Cited by
Sorted by citations
JAKs and STATs in immunity, immunodeficiency, and cancer
O'Shea, J. J., Holland, S. M., & Staudt, L. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1202117 · Cited by 927
Self-citationTargeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
Engelman, J. A., Zejnullahu, K., Gale, C.-M., Lifshits, E., Gonzales, A. J., Shimamura, T., Zhao, F., Vincent, P. W., Naumov, G. N., Bradner, J. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1885 · Cited by 730
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases
Schwartz, D. M., Bonelli, M., Gadina, M., & O'Shea, J. J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.167 · Cited by 648
Self-citationJanus kinase-targeting therapies in rheumatology: A mechanisms-based approach
Tanaka, Y., Luo, Y., O’Shea, J. J., & Nakayamada, S. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00726-8 · Cited by 501
Self-citation
Metadata
- Authors
- Changelian, P. S., Flanagan, M. E., Ball, D. J., Kent, C. R., Magnuson, K. S., Martin, W. H., Rizzuti, B. J., Sawyer, P. S., Perry, B. D., Brissette, W. H., McCurdy, S. P., Kudlacz, E. M., Conklyn, M. J., Elliott, E. A., Koslov, E. R., Fisher, M. B., Strelevitz, T. J., Yoon, K., Whipple, D. A., Sun, J., Munchhof, M. J., Doty, J. L., Casavant, J. M., Blumenkopf, T. A., Hines, M., Brown, M. F., Lillie, B. M., Subramanyam, C., Shang-Poa, C., Milici, A. J., Beckius, G. E., Moyer, J. D., Su, C., Woodworth, T. G., Gaweco, A. S., Beals, C. R., Littman, B. H., Fisher, D. A., Smith, J. F., Zagouras, P., Magna, H. A., Saltarelli, M. J., Johnson, K. S., Nelms, L. F., Des Etages, S. G., Hayes, L. S., Kawabata, T. T., Finco-Kent, D., Baker, D. L., Larson, M., Si, M.-S., Paniagua, R., Higgins, J., Holm, B., Reitz, B., Zhou, Y.-J., Morris, R. E., O'Shea, J. J., & Borie, D. C.
- Affiliations
- Immunology Group, Department of Antibacterials and Immunology, Pfizer Global Researchand Development, Groton, CT 06340, USA.
- Venue
- Science
- Published
- 2003-10-31
- Volume
- 302
- Issue
- 5646
- Pages
- 875-878
- ISSN
- 0036-8075
- 1095-9203
- Cited by
- 607
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor. https://app.cochat.ai/papers/10.1126/science.1087061
- The paper
- Changelian, P. S., Flanagan, M. E., Ball, D. J., Kent, C. R., Magnuson, K. S., Martin, W. H., Rizzuti, B. J., Sawyer, P. S., Perry, B. D., Brissette, W. H., McCurdy, S. P., Kudlacz, E. M., Conklyn, M. J., Elliott, E. A., Koslov, E. R., Fisher, M. B., Strelevitz, T. J., Yoon, K., Whipple, D. A., . . . Borie, D. C. (2003). Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor. Science. https://doi.org/10.1126/science.1087061